A new CRISPR-powered light sensor can detect the faintest whispers of cancer in a single drop of blood.

Heather Quintana Suchan, a mother living with stage 4 lung cancer, is using her platform to encourage other patients to pursue biomarker testing and genomic profiling early in the diagnostic process, ...

Heather Quintana Suchan, a mother and music industry professional living with stage 4 lung cancer, shared how her diagnosis ...

Imagine this: someone you love has just heard the words “you have cancer.” They are meeting with their oncologist – perhaps even me, or one of my colleagues – and come to understand that there is ...

Almost all of us have been touched by cancer at some point in our lives. If we haven’t had it, chances are we know a loved one or a friend who has. When someone dies from cancer, families go through ...

Researchers have developed a highly sensitive light-based sensor that can detect extremely low concentrations of cancer biomarkers in the blood. The new technology could one day make it possible to ...

Mississippi is a hot spot in the nation for Alzheimer’s disease. Now lawmakers are being urged to support early diagnosis ...

Across all cancer types, less than 50% of patients underwent biomarker testing before first-line treatment. Many patients with advanced cancer do not receive guideline-recommended biomarker testing ...

—A new study of more than 42,000 patients sought to evaluate contemporary trends in testing for biomarkers of non-small cell lung cancer (NSCLC), as well as rates of treatment with ...

Mississippi's House Bill 565, known as Jill's Law, aims to provide coverage for biomarker testing to improve cancer treatment ...

Researchers have developed a highly sensitive light-based sensor that can detect extremely low concentrations of cancer ...

Understanding those genetic “errors” has become central to modern lung cancer care. Biomarker testing, sometimes called ...